Oncternal Therapeutics, Inc. - stock earnings
ONCT Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | - / -2.9351000000 | - | - / 180203 | - |
ONCT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -9.2 million USD | 297000 USD |
| 2023Q3 | -9.9 million USD | 179000 USD |
| 2023Q2 | -9.0 million USD | 106000 USD |
| 2023Q1 | -11.5 million USD | 203000 USD |
| 2022Q4 | -10.9 million USD | 171000 USD |
| 2022Q3 | -10.7 million USD | 382000 USD |
| 2022Q2 | -11.6 million USD | 191000 USD |
| 2022Q1 | -9.9 million USD | 746000 USD |
| 2021Q4 | -8.1 million USD | 556000 USD |
| 2021Q3 | -9.6 million USD | 2.1 million USD |
| 2021Q2 | -7.7 million USD | 883000 USD |
| 2021Q1 | -5.9 million USD | 748000 USD |
| 2020Q4 | -2.6 million USD | 1.6 million USD |
| 2020Q3 | -4.4 million USD | 585000 USD |
| 2020Q2 | -5.5 million USD | 623000 USD |
| 2020Q1 | -4.7 million USD | 578000 USD |
| 2019Q4 | -4.2 million USD | 736000 USD |
| 2019Q3 | -4.9 million USD | 544000 USD |
| 2019Q2 | -22.8 million USD | 674000 USD |
| 2019Q1 | -5.8 million USD | 470000 USD |
| 2018Q4 | -5.4 million USD | ? USD |
| 2018Q3 | -9.4 million USD | 329000 USD |
| 2018Q2 | -10.0 million USD | 1.5 million USD |
| 2018Q1 | -13.6 million USD | 188000 USD |
| 2017Q4 | -9.3 million USD | ? USD |
| 2017Q3 | -8.5 million USD | ? USD |
| 2017Q2 | -6.4 million USD | ? USD |
| 2017Q1 | -6.3 million USD | ? USD |
| 2016Q4 | -6.9 million USD | -2.5 million USD |
| 2016Q3 | -6.9 million USD | ? USD |
| 2016Q2 | -6.1 million USD | ? USD |
| 2016Q1 | 2.1 million USD | ? USD |
| 2015Q4 | -3.2 million USD | ? USD |
| 2015Q3 | 34.9 million USD | ? USD |
| 2015Q2 | -48.0 million USD | ? USD |
| 2015Q1 | -2.4 million USD | ? USD |
| 2014Q4 | -14.5 million USD | ? USD |
| 2014Q3 | -4.9 million USD | ? USD |
| 2014Q2 | -10.9 million USD | ? USD |
| 2014Q1 | -9.0 million USD | ? USD |
| 2013Q4 | -7.8 million USD | ? USD |
| 2013Q3 | -8.9 million USD | ? USD |
| 2013Q2 | -12.8 million USD | ? USD |
| 2013Q1 | -12.6 million USD | ? USD |
| 2012Q4 | -10.7 million USD | -3.5 million USD |
| 2012Q3 | 7.4 million USD | ? USD |
| 2012Q2 | -10.4 million USD | 1.6 million USD |
| 2012Q1 | -11.1 million USD | 1.8 million USD |
| 2011Q4 | -10.7 million USD | 1.8 million USD |
| 2011Q3 | -9.3 million USD | 2.0 million USD |
| 2011Q2 | -10.7 million USD | 1.6 million USD |
| 2011Q1 | -2.6 million USD | 9.3 million USD |
| 2010Q4 | -7.5 million USD | 1.8 million USD |
| 2010Q3 | -8.6 million USD | 1.3 million USD |
| 2010Q2 | -12.9 million USD | 935000 USD |
| 2010Q1 | 44.3 million USD | 56.6 million USD |
| 2009Q4 | -10.9 million USD | 3.7 million USD |
| 2009Q3 | -12.8 million USD | 3.6 million USD |
| 2009Q2 | -11.3 million USD | 3.8 million USD |
| 2009Q1 | -11.3 million USD | 3.6 million USD |
| 2008Q4 | -13.9 million USD | 3.0 million USD |
| 2008Q3 | -11.9 million USD | 3.0 million USD |
| 2008Q2 | -13.2 million USD | 3.0 million USD |
| 2008Q1 | -12.7 million USD | 4.5 million USD |
| 2007Q4 | -12.8 million USD | 1.9 million USD |
| 2007Q3 | -10.2 million USD | 1.7 million USD |
| 2007Q2 | -9.2 million USD | 1.8 million USD |
| 2007Q1 | -8.1 million USD | 1.7 million USD |
| 2006Q4 | -4.7 million USD | 4.6 million USD |
| 2006Q3 | -10.9 million USD | 1.1 million USD |
| 2006Q2 | -10.0 million USD | 623000 USD |
| 2006Q1 | -9.9 million USD | 1.2 million USD |
| 2005Q4 | -7.8 million USD | 646000 USD |
| 2005Q3 | -9.9 million USD | 622000 USD |
| 2005Q2 | -10.0 million USD | 1.8 million USD |
| 2005Q1 | -9.1 million USD | 687000 USD |
| 2004Q4 | -6.9 million USD | 344000 USD |
| 2004Q3 | -5.1 million USD | 377000 USD |
| 2004Q2 | -4.5 million USD | 1.1 million USD |
| 2004Q1 | -5.8 million USD | 52000 USD |
| 2003Q4 | -4.5 million USD | ? USD |
| 2003Q3 | -3.4 million USD | ? USD |
| 2003Q2 | -3.5 million USD | ? USD |
| 2003Q1 | -2.8 million USD | ? USD |
ONCT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -39.5 million USD | 785000 USD |
| 2022 | -43.4 million USD | 1.5 million USD |
| 2021 | -31.3 million USD | 4.3 million USD |
| 2020 | -17.2 million USD | 3.4 million USD |
| 2019 | -15.9 million USD | 2.4 million USD |
| 2018 | -38.4 million USD | 2.5 million USD |
| 2017 | -30.4 million USD | 1.7 million USD |
| 2016 | -17.7 million USD | -2.5 million USD |
| 2015 | -18.7 million USD | ? USD |
| 2014 | -39.4 million USD | ? USD |
| 2013 | -42.1 million USD | ? USD |
| 2012 | -27.1 million USD | ? USD |
| 2011 | -33.3 million USD | 14.7 million USD |
| 2010 | 15.3 million USD | 60.6 million USD |
| 2009 | -46.3 million USD | 14.7 million USD |
| 2008 | -51.8 million USD | 13.5 million USD |
| 2007 | -40.4 million USD | 7.1 million USD |
| 2006 | -35.5 million USD | 7.5 million USD |
| 2005 | -36.8 million USD | 3.8 million USD |
| 2004 | -22.3 million USD | 1.9 million USD |
| 2003 | -14.2 million USD | ? USD |
| 2002 | -11.9 million USD | ? USD |
| 2001 | -8.1 million USD | ? USD |
| 2000 | -3.8 million USD | ? USD |
| 1999 | -750000 USD | ? USD |
ONCT
Price: $8.74
52 week price:
Earnings Per Share: -13.43 USD
P/E Ratio: -0.70
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 91400
Market Capitalization: 25.6 million